Le Lézard
Classified in: Health, Science and technology
Subject: PDT

R3 International Now Offering Stem Cell Therapy Program for Crohns Disease, IBD and Ulcerative Colitis


SAN DIEGO, July 8, 2020 /PRNewswire-PRWeb/ -- R3 International is now offering effective stem cell therapy for Crohns disease, Ulcerative Colitis and IBD with a new program in Mexico. The new program provides up to 200 million stem cells for patients, with treatment starting at only $2975.

Millions of individuals worldwide suffer from chronic abdominal issues that affect every aspect of daily life and lead to difficulty with functioning. Traditional treatments are often insufficient and entail significant side effects.

According to R3 CEO David Greene, MD, MBA, "Stem cell therapy for Crohns, UC and IBD is not only safe and effective, but you don't have the bad side effects like you do with traditional drugs. We've been very successful in Mexico because the therapies are not only clinically and cost effective, but we offer very high numbers of stem cells for pricing exponentially less than the US, Panama or others!"

Studies on stem cell therapy for inflammatory diseases such as Crohns are showing that they are highly effective at regulating one's immune response (Nat Rev Nephrol 2018). This typically helps reduce flare ups and pain in patients, helping to increase quality of life tremendously.

Since R3 Stem Cell International opened in Tijuana, outcomes for these inflammatory conditions have been tremendous, with patients receiving anywhere from 30 million to 200 million stem cells.

The cells offered at R3 International come from a lab with a perfect safety record and quality assurance standards that exceed those of the FDA. No preservative is necessary, so the cell viability for the biologic exceeds 95% typically.

According to CEO Dr. Greene, "We made sure to partner with a lab that has a perfect safety record and only cultures cells between three and five generations. This means counts are high, and so is the potency of the cells!"

The treatment process starts with a free phone consultation with one of R3's licensed, experienced stem cell doctors. Once the treatment recommendation is made and the procedure is scheduled, the patient's designated concierge representative will assist with travel logistics. Transportation is included to and from the clinic from San Diego International Airport, which is only 20 minutes away.

Treatment starts at $2975 for 30 million live stem cells, and goes up $1000 for a total of 50 million. If a patient desires, a five day stay will include three treatments totaling 150 to 200 million stem cells. Or there is an option for four visits over a year as well, both starting at $8975 all inclusive.

To start the seamless process of obtaining treatment, visit for more information and call (888) 988-0515 to schedule the phone consultation.

 

SOURCE R3 Stem Cell International


These press releases may also interest you

13 aoû 2020
Some of music's biggest names brought the fun and excitement of a music festival into viewer's homes early today for a virtual festival called Music Gives: Together #forStJude. The event was held to raise funds and awareness in support of St. Jude...

13 aoû 2020
Amgen Inc. announced today the pricing terms of its previously announced nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") certain specified series of its outstanding senior notes...

13 aoû 2020
Isagenix International, a global wellbeing company providing effective products and a supportive community, has announced four new Canada finalists in its annual total-body transformation program, the IsaBody Challenge®. The second Judging Period's...

13 aoû 2020
K-Bro Linen Inc. ("K-Bro" or the "Corporation") today announces its 2020 Q2 financial and operating results. 2020 Q2 Financial and Operating Highlights As a result of the COVID-19 pandemic, consolidated hospitality revenue for the three months...

13 aoû 2020
Inc. Magazine Unveils Its Annual List of America's Fastest-Growing Private Companies ? the Inc. 5000 For the 3rd Consecutive Year, Advanced Medical Integration Appears on the Inc. 5000, Ranking No. 2489 for 2020 Inc. magazine has revealed that...

13 aoû 2020
Formsense, a leading smart apparel company, has taken on the unusual role as part of an expert task force working together with Mass General Brigham Health System and its Spaulding Rehabilitation Network to publish a study on the role of mHealth in...



News published on 8 july 2020 at 00:00 and distributed by: